ALL risk stratification gene panel covers the following:"(Hotspot genes: DNMT3A, HRAS, KRAS, NRAS, ABL1; Full gene: PHF6 Gene fusions: RUNX1 Expression control gene: FBXW2. It is a comprehensive genetic test used to detect and identify specific genetic alterations associated with T-Acute Lymphoblastic Leukemia. It utilizes next-generation sequencing (NGS) technology to simultaneously analyze multiple genes known to be implicated in these malignancies. The panel provides valuable information about gene mutations, gene fusions, and other genetic alterations that can aid in diagnosis, prognosis, and treatment decisions. The test allows for a more targeted and personalized approach to managing T-ALL.
Contains4 tests
Earliest reports in18 days
Samples requiredBlood
ForMen & women
What does ALL Risk Stratification Gene Panel- T - ALL measure?
Package contains 4 tests
Full Gene : PHF6
Hotspot Genes : DNMT3A, HRAS, KRAS, NRAS, ABL1
Gene Fusions : RUNX1
Expression Control Gene : FBXW2
Samples required
BloodOur phlebotomist will draw a blood sample, typically from a vein in your inner elbow.